Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Cpi - Del Caribe: medical device reports filed with FDA

64,617 reports name it as the manufacturer of the device involved, 2003–2023.

64,617
reports naming it as manufacturer
0.3% of all MAUDE reports
0
reports, 12 months to August 2026
0 in the 12 months before
25.1%
classified as malfunction
62.3% across all reports
1%
classified as death, as reported
0.9% across all reports

64,617 medical device reports received by FDA give Cpi - Del Caribe as the manufacturer of the device involved, 0.3% of the MAUDE database, from February 2003 to August 2023. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (73.9%), malfunction (25.1%) and death (1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Endotak ReliancePermanent defibrillator electrodes20,1692381.2%
IngevityImplantable pulse generator, pacemaker (non-crt)8,2352990.9%
FlextendPermanent pacemaker electrode4,4952030.7%
Easytrak 2Drug eluting permanent left ventricular (lv) pacemaker electrode3,678180.8%
AcuityImplantable pulse generator, pacemaker (non-crt)2,63861%
Reliance G Active Fix Dual Coil 64cmImplantable cardioverter defibrillator (non-crt)1,22500.1%
Endotak EndurancePermanent defibrillator electrodes95411.6%
Easytrak 3Drug eluting permanent left ventricular (lv) pacemaker electrode69112.4%
Selute PicotipDrug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes67200.8%
Flextend Is-1 Bi Positive Fix Ra/Rv 52 CmPermanent pacemaker electrode65200%
Reliance G Active Fix Dual Coil 59cmImplantable cardioverter defibrillator (non-crt)62100%
Reliance Active Fix Dual Coil Is-1/Df-1 64cmImplantable cardioverter defibrillator (non-crt)59200.2%
EasytrakDefibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)42301.5%
Flextend Is-1 Bi Positive Fix Ra/Rv 59 CmPermanent pacemaker electrode37700%
Sweet PicotipPermanent pacemaker electrode31701.3%
Sweet TipDrug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes31500.7%
Reliance Active Fix Dual Coil Is-1/Df-1 59cmImplantable cardioverter defibrillator (non-crt)28000%
Endotak DspImplantable cardioverter defibrillator (non-crt)271141.6%
Reliance Passive Dual Coil Is-1/Df-1 64cmPermanent pacemaker electrode26000.4%
Reliance G Passive Dual Coil 64cmImplantable cardioverter defibrillator (non-crt)25600.4%
Easytrak 2 Lva Dual Electrode Is-1 Passive 90cmImplantable pulse generator, pacemaker (non-crt)22900%
Reliance Sg Active Fix Single Coil 64cmImplantable cardioverter defibrillator (non-crt)19700%
Flextend Is-1 Bi Positive Fix Ra/Rv 45 CmPermanent pacemaker electrode18900%
Easytrak 2 Lva Dual Electrode Lv-1 Passive 90cmImplantable pulse generator, pacemaker (non-crt)16900%
SeluteDrug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes16900.9%
TransvenousDrug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes16200.2%
Endotak Dsp Is-1/Df-1 Tines Tri 70cmImplantable cardioverter defibrillator (non-crt)11500%
ThinlinePermanent pacemaker electrode401.3%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
NVYPermanent defibrillator electrodes14,56622.5%
DTBPermanent pacemaker electrode13,26720.5%
NVNDrug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes12,03318.6%
LWSImplantable cardioverter defibrillator (non-crt)11,74918.2%
LWPImplantable pulse generator, pacemaker (non-crt)6,65710.3%
OJXDrug eluting permanent left ventricular (lv) pacemaker electrode4,3446.7%
NIKDefibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)1,8872.9%
DTDPacemaker lead adaptor530.1%
DXYImplantable pacemaker pulse-generator330.1%
NVZPulse generator, permanent, implantable40%

Reports by month, five years

01019Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 19Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death1%615
Injury73.9%47,774
Malfunction25.1%16,216
Other0%6
Not given0%6

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Cpi - Del Caribe reports

How many FDA device reports name Cpi - Del Caribe as manufacturer?

64,617 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Endotak Reliance (20,169), Ingevity (8,235), Flextend (4,495), Easytrak 2 (3,678) and Acuity (2,638).

Which device types does it report on?

permanent defibrillator electrodes (22.5%), permanent pacemaker electrode (20.5%), drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (18.6%) and implantable cardioverter defibrillator (non-crt) (18.2%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.